SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-24-000175
Filing Date
2024-02-06
Accepted
2024-02-06 09:34:04
Documents
18
Period of Report
2024-02-05
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K scpx_8knc.htm   iXBRL 8-K 31772
2 CERTIFICATE OF AMENDMENT ex3x1.htm EX-3.1 7708
3 PRESS RELEASE ex99x1.htm EX-99.1 7185
4 GRAPHIC image_001.jpg GRAPHIC 10182
  Complete submission text file 0001079973-24-000175.txt   289145

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE scpx-20240205.xsd EX-101.SCH 3534
6 XBRL DEFINITION FILE scpx-20240205_def.xml EX-101.DEF 27011
7 XBRL LABEL FILE scpx-20240205_lab.xml EX-101.LAB 37203
8 XBRL PRESENTATION FILE scpx-20240205_pre.xml EX-101.PRE 25632
19 EXTRACTED XBRL INSTANCE DOCUMENT scpx_8knc_htm.xml XML 5719
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 24598353
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)